FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3206757457> ?p ?o ?g. }

• W3206757457 endingPage "e1009965" @default.
• W3206757457 startingPage "e1009965" @default.
• W3206757457 abstract "Mycobacterium abscessus is the most common rapidly growing non-tuberculous mycobacteria to cause pulmonary disease in patients with impaired lung function such as cystic fibrosis. M. abscessus displays high intrinsic resistance to common antibiotics and inducible resistance to macrolides like clarithromycin. As such, M. abscessus is clinically resistant to the entire regimen of front-line M. tuberculosis drugs, and treatment with antibiotics that do inhibit M. abscessus in the lab results in cure rates of 50% or less. Here, we identified epetraborole (EPT) from the MMV pandemic response box as an inhibitor against the essential protein leucyl-tRNA synthetase (LeuRS) in M. abscessus. EPT protected zebrafish from lethal M. abscessus infection and did not induce self-resistance nor against clarithromycin. Contrary to most antimycobacterials, the whole-cell activity of EPT was greater against M. abscessus than M. tuberculosis, but crystallographic and equilibrium binding data showed that EPT binds LeuRSMabs and LeuRSMtb with similar residues and dissociation constants. Since EPT-resistant M. abscessus mutants lost LeuRS editing activity, these mutants became susceptible to misaminoacylation with leucine mimics like the non-proteinogenic amino acid norvaline. Proteomic analysis revealed that when M. abscessus LeuRS mutants were fed norvaline, leucine residues in proteins were replaced by norvaline, inducing the unfolded protein response with temporal changes in expression of GroEL chaperonins and Clp proteases. This supports our in vitro data that supplementation of media with norvaline reduced the emergence of EPT mutants in both M. abscessus and M. tuberculosis. Furthermore, the combination of EPT and norvaline had improved in vivo efficacy compared to EPT in a murine model of M. abscessus infection. Our results emphasize the effectiveness of EPT against the clinically relevant cystic fibrosis pathogen M. abscessus, and these findings also suggest norvaline adjunct therapy with EPT could be beneficial for M. abscessus and other mycobacterial infections like tuberculosis." @default.
• W3206757457 created "2021-10-25" @default.
• W3206757457 creator A5017901126 @default.
• W3206757457 creator A5029379360 @default.
• W3206757457 creator A5048959876 @default.
• W3206757457 creator A5056305582 @default.
• W3206757457 creator A5070433731 @default.
• W3206757457 creator A5074808929 @default.
• W3206757457 creator A5077811344 @default.
• W3206757457 creator A5085498173 @default.
• W3206757457 creator A5088232668 @default.
• W3206757457 date "2021-10-12" @default.
• W3206757457 modified "2023-09-24" @default.
• W3206757457 title "Efficacy of epetraborole against Mycobacterium abscessus is increased with norvaline" @default.
• W3206757457 cites W1539796472 @default.
• W3206757457 cites W1900644743 @default.
• W3206757457 cites W1977479782 @default.
• W3206757457 cites W1982891627 @default.
• W3206757457 cites W1990673356 @default.
• W3206757457 cites W2004416250 @default.
• W3206757457 cites W2009746802 @default.
• W3206757457 cites W2018209201 @default.
• W3206757457 cites W2025451615 @default.
• W3206757457 cites W2030545256 @default.
• W3206757457 cites W2034080889 @default.
• W3206757457 cites W2066392481 @default.
• W3206757457 cites W2071711178 @default.
• W3206757457 cites W2073186433 @default.
• W3206757457 cites W2081935857 @default.
• W3206757457 cites W2091067056 @default.
• W3206757457 cites W2092605558 @default.
• W3206757457 cites W2098167941 @default.
• W3206757457 cites W2115094449 @default.
• W3206757457 cites W2124026197 @default.
• W3206757457 cites W2124297238 @default.
• W3206757457 cites W2136307168 @default.
• W3206757457 cites W2137233414 @default.
• W3206757457 cites W2142002745 @default.
• W3206757457 cites W2142447693 @default.
• W3206757457 cites W2149808870 @default.
• W3206757457 cites W2150214731 @default.
• W3206757457 cites W2162625328 @default.
• W3206757457 cites W2167597232 @default.
• W3206757457 cites W2171495098 @default.
• W3206757457 cites W2342849480 @default.
• W3206757457 cites W2511758086 @default.
• W3206757457 cites W2544182179 @default.
• W3206757457 cites W2566555771 @default.
• W3206757457 cites W2585341756 @default.
• W3206757457 cites W2586637020 @default.
• W3206757457 cites W2618895297 @default.
• W3206757457 cites W2620857307 @default.
• W3206757457 cites W2766733233 @default.
• W3206757457 cites W2786390877 @default.
• W3206757457 cites W2886931860 @default.
• W3206757457 cites W2913689157 @default.
• W3206757457 cites W2952582089 @default.
• W3206757457 cites W2990176834 @default.
• W3206757457 cites W2990690083 @default.
• W3206757457 cites W3014674861 @default.
• W3206757457 cites W3042053930 @default.
• W3206757457 doi "https://doi.org/10.1371/journal.ppat.1009965" @default.
• W3206757457 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8535176" @default.
• W3206757457 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34637487" @default.
• W3206757457 hasPublicationYear "2021" @default.
• W3206757457 type Work @default.
• W3206757457 sameAs 3206757457 @default.
• W3206757457 citedByCount "15" @default.
• W3206757457 countsByYear W32067574572021 @default.
• W3206757457 countsByYear W32067574572022 @default.
• W3206757457 countsByYear W32067574572023 @default.
• W3206757457 crossrefType "journal-article" @default.
• W3206757457 hasAuthorship W3206757457A5017901126 @default.
• W3206757457 hasAuthorship W3206757457A5029379360 @default.
• W3206757457 hasAuthorship W3206757457A5048959876 @default.
• W3206757457 hasAuthorship W3206757457A5056305582 @default.
• W3206757457 hasAuthorship W3206757457A5070433731 @default.
• W3206757457 hasAuthorship W3206757457A5074808929 @default.
• W3206757457 hasAuthorship W3206757457A5077811344 @default.
• W3206757457 hasAuthorship W3206757457A5085498173 @default.
• W3206757457 hasAuthorship W3206757457A5088232668 @default.
• W3206757457 hasBestOaLocation W32067574571 @default.
• W3206757457 hasConcept C104317684 @default.
• W3206757457 hasConcept C143065580 @default.
• W3206757457 hasConcept C2776111603 @default.
• W3206757457 hasConcept C2776580952 @default.
• W3206757457 hasConcept C2776962512 @default.
• W3206757457 hasConcept C2780374374 @default.
• W3206757457 hasConcept C2781470083 @default.
• W3206757457 hasConcept C501593827 @default.
• W3206757457 hasConcept C515207424 @default.
• W3206757457 hasConcept C523546767 @default.
• W3206757457 hasConcept C54355233 @default.
• W3206757457 hasConcept C55493867 @default.
• W3206757457 hasConcept C86803240 @default.
• W3206757457 hasConcept C89423630 @default.
• W3206757457 hasConceptScore W3206757457C104317684 @default.
• W3206757457 hasConceptScore W3206757457C143065580 @default.

• next